SECUKINUMAB SURVIVAL AND SAFETY BASED ON DEMOGRAPHIC CHARACTERISTICS IN SPONDYLOARTHRITIS AND PSORIASIC ARTHRITIS IN A REAL CLINICAL SETTING.

被引：0
|
作者：
Lopez, I. Marta [1 ]
Astigarraga, Uxue [2 ]
Pineiro, Irene [2 ]
Ibarrola, Libe [2 ]
Mendizabal, Javier [2 ]
Sada, Guillen [2 ]
Fito Manteca, Concepcion [2 ]
机构：
[1] Hosp Univ Arava, Vitoria, Spain
[2] Hosp Univ Navarra, Pamplona, Spain
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2023年 / 29卷
关键词：
Safety; Secukinumab; Survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PANLAR2023
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [41] Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14
    Auliac, J. B.
    Bayle, S.
    Vergnenegre, A.
    Fraboulet, G.
    Lecaer, H.
    Falchero, L.
    Do, P.
    Doubre, H.
    Hauss, P. A.
    Vinas, A.
    Larive, S.
    Chiappa, A. M.
    Marin, B.
    Chouaid, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [42] Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14
    Jean-Bernard Auliac
    Pascal Dô
    Sophie Bayle
    Hélène Doubre
    Florent Vinas
    Jacques Letreut
    Lionel Falchero
    Pierre Alexandre Hauss
    Pascal Thomas
    Christos Chouaid
    Advances in Therapy, 2019, 36 : 2161 - 2166
  • [43] Demographic, clinical, and disease characteristics of patients with atrial fibrillation on edoxaban therapy according to the bleeding risk: A report from evaluation of treatment safety in patients with atrial fibrillation on edoxaban therapy in real
    Avci, Eyup
    Akgun, Didar Elif
    Arslan, Ugur
    Inci, Sinan
    Yildirim, Ozge Turgay
    Yenercag, Mustafa
    Kasap, Mithat
    Turk, Ugur Onsel
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S101 - S103
  • [44] Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02-14
    Auliac, Jean-Bernard
    Do, Pascal
    Bayle, Sophie
    Doubre, Helene
    Vinas, Florent
    Letreut, Jacques
    Falchero, Lionel
    Hauss, Pierre Alexandre
    Thomas, Pascal
    Chouaid, Christos
    ADVANCES IN THERAPY, 2019, 36 (08) : 2161 - 2166
  • [45] How well do clinical and demographic characteristics predict Patient Health Questionnaire-9 scores among patients with treatment-resistant major depressive disorder in a real-world setting?
    Voelker, Jennifer
    Joshi, Kruti
    Daly, Ella
    Papademetriou, Eros
    Rotter, David
    Sheehan, John J.
    Kuvadia, Harsh
    Liu, Xing
    Dasgupta, Anandaroop
    Potluri, Ravi
    BRAIN AND BEHAVIOR, 2021, 11 (02):
  • [46] Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
    Miyazaki, Yusuke
    Nakano, Kazuhisa
    Nakayamada, Shingo
    Kubo, Satoshi
    Inoue, Yoshino
    Fujino, Yoshihisa
    Tanaka, Yoshiya
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (09) : 1130 - 1136
  • [47] Demographic and Clinical Characteristics of Patients With Type 2 Diabetes on Basal Insulin Associated With Initiating GLP-1 versus DPP-4 Treatment Regimens: Insights From a Real-World Setting in the US
    Dalal, Mehul
    Karve, Sudeep
    Candrilli, Sean
    Digenio, Andres
    DIABETES, 2013, 62 : A660 - A660
  • [48] Demographic, clinical, and disease characteristics of patients with atrial fibrillation on edoxaban therapy according to the stroke risk: A report from evaluation of treatment safety in patients with atrial fibrillation on edoxaban therapy in real-life data
    Akgun, Didar Elif
    Avci, Eyup
    Yavuz, Veysel
    Isik, Turgay
    Topuz, Sahin
    Uludag, Demet Menekse Gerede
    Totan, Sahin
    Turk, Ugur Onsel
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 : S58 - S59
  • [49] Prognostic importance of objective response (OR) to chemotherapy for time to progression (TTP) and survival time (ST) in advanced non-small cell lung cancer (NSCLC): Analysis of individual patient data from platinum-based clinical trials in monocentric setting.
    Radosavlievic, DZ
    Jelic, S
    Tomasevic, Z
    Kezic, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
  • [50] Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean population
    Jeon, Da Som
    Kim, Jin Woo
    Kim, Seul Gi
    Kim, Hyeong Ryul
    Song, Si Yeol
    Lee, Jae Cheol
    Ji, Wonjun
    Choi, Chang-Min
    Kim, Ho Cheol
    THORACIC CANCER, 2022, 13 (18) : 2584 - 2591
12345